INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 13, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 4 | Other acquisition or disposition | -- | -- | 64,058 |
| Feb 10, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Other acquisition or disposition | -- | -- | 591,348 |
| Feb 10, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Other acquisition or disposition | -- | -- | 500,000 |
| Feb 10, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Other acquisition or disposition | -- | -- | 5,676 |
| Dec 19, 2016 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,676 |
| Dec 18, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
| Dec 18, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 567,976 |
| Dec 04, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
| Nov 03, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
| Nov 03, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 569,588 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.